俯卧部分乳房照射 (PBI):一项前瞻性随机试验
俯卧部分乳房照射 (PBI):一项比较五个与三个分数的前瞻性随机试验
The purpose of this study is to test whether a radiotherapy regimen of 8 GY x 3 days over 5 days (every other day) is as safe (well-tolerated) and effective as 6 Gy x 5 over five consecutive days
研究概览
详细说明
Despite the fact that less extensive experience than that of brachytherapy is available, PBI delivery through an external-beam has many advantages. First of all, it is likely to be more acceptable to the patient since it is non-invasive and it does not require a surgical procedure or anesthesia. Moreover, since it is delivered after surgery, the pathological analysis of the segmental mastectomy specimen is available to inform the selection of the best candidates. In addition, EB-PBI is likely to become more widely reproducible, since it does not rely on the experience and skills of the radiation oncologist performing the brachytherapy implant. Besides, once the technique is established, it can be widely applied at any facility provided with a linear accelerator, without the risk presented by some brachytherapy approaches that can not be completed because of the unfavorable interplay of patient's anatomy with the technical limitations of the applicator.
The women in this study will receive either 5 or 3 radiation fractions to the tumor bed. We have chosen to study T1 post menopausal women because in this subset: 1) the tumor is small enough to be treated by partial breast radiation 2) the odds of having multicentric disease are low, making it ethical to avoid whole breast irradiation, 3) the most benefit from reducing the radiation schedule from 5 to 3 could be expected.
All patients will receive either 8 Gy x 3 over 5 days, every other day or 6 Gy x 5 over 5 days, on five consecutive days
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
New York
-
New York、New York、美国、10016
- NYU Langone Medical Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Post-menopausal women defined as either:
- at least 2 years without menstrual period
- patients older than 50 with serological evidence of post-menopausal status
- hysterectomized patients of any age with FSH confirmation of post- menopausal status
-
pT1 breast cancer, excised with negative margins. Criteria for low risk-pTis:
- Screen-detected
- Low to intermediate nuclear grade
- < 2.5cm in size
- Resected with negative margins at >3mm)
-
clinically N0 or pN0 or sentinel node negative breast cancer
Exclusion Criteria:
- previous radiation therapy to the ipsilateral breast
- presence of a proportion of DCIS in the core biopsy specimen which is compatible with extensive intraductal component (EIC)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:PBI Radiotherapy 6 Gy
Prone partial breast irradiation of 6 Gy x 5 over 5 days, on five consecutive days |
Patients will receive 3D-Conformal or Intensity Modulated Radiation Therapy (IMRT) of 6 Gy x 5, over 5 consecutive days
其他名称:
|
|
实验性的:PBI Radiotherapy 8 Gy
Prone partial breast irradiation of 8 Gy x 3 over 5 days, every other day |
Patients will receive 3D-Conformal or Intensity Modulated Radiation Therapy (IMRT) of 8 Gy x 3, over 5 days, every other day
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
患有 2 级或 3 级纤维化的参与者的百分比
大体时间:60个月
|
60个月
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
孤立的局部/区域复发率
大体时间:随机化后 1 年
|
随机化后 1 年
|
|
局部/区域和远处同时复发率
大体时间:随机化后 1 年
|
随机化后 1 年
|
|
孤立的局部/区域复发率
大体时间:随机化后 2 年
|
随机化后 2 年
|
|
局部/区域和远处同时复发率
大体时间:随机化后 2 年
|
随机化后 2 年
|
|
孤立的局部/区域复发率
大体时间:随机分组后 3 年
|
随机分组后 3 年
|
|
局部/区域和远处同时复发率
大体时间:随机分组后 3 年
|
随机分组后 3 年
|
合作者和调查者
调查人员
- 首席研究员:Naamit Gerber, MD、NYU Langone Medical Center
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.